Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10
November 25 Product: Shorla Oncologys Imkeldi Indication: Several forms of leukemia and other cancers The FDA on Monday signed off on Shorla Oncologys Imkeldi, an oral solution indicated for the treatment of certain types of chronic myeloid leukemia and acute lymphoblastic leukemia, as well as other cancers such as myelodysplastic/myeloproliferative diseases, aggressive systemic mastocytosis and dermatofibrosarcoma protuberans
Small case series and retrospective reviews suggest the combination produces 15-20% body weight loss in patients who didnt respond well to either alone
It works from within your body to reduce the melanin production, causing a lighter skin and more evenly spread complexion
,
Pureza: 99% certificada por HPLC Especificaciones tcnicas Presentacin: polvo liofilizado en vial de 10mg Pureza: 99% (COA disponible) Almacenamiento: liofilizado a 20C
It is not intended for human or animal consumption, therapeutic use, clinical application, or diagnostic purposes
US$ 23.44
US$ 21.52
US$ 20.25
US$ 19.99
US$ 24.82
